ChemicalBook > CAS DataBase List > 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-
- CAS No.722544-51-6
- Chemical Name:1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-
- CBNumber:CB01512456
- Molecular Formula:C26H30FN7O3
- Formula Weight:507.56
- MOL File:722544-51-6.mol
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- Property
- Boiling point 796.7±60.0 °C(Predicted)
- Density 1.359±0.06 g/cm3(Predicted)
- storage temp. 2-8°C
- solubility DMSO: >15mg/mL
- pka 13.07±0.10(Predicted)
- form powder
- color white to beige
- Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
- InChIKey QYZOGCMHVIGURT-UHFFFAOYSA-N
- CAS DataBase Reference 722544-51-6
- FDA UNII 29P8LWS24N
- NCI Drug Dictionary barasertib
- UNSPSC Code 12352200
- NACRES NA.77
Safety
- WGK Germany :3
-
Symbol(GHS)
- Signal wordWarning
- Hazard statements H302
- Precautionary statements P280-P305+P351+P338
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- Price
More Price(2)
- Brand: Sigma-Aldrich(India)
- Product number: SML0268
- Product name : AZD1152-HQPA
- Purity: ≥98% (HPLC)
- Packaging: 10MG
- Price: ₹11677.2
- Updated: 2022/06/14
- Buy: Buy
- Brand: Sigma-Aldrich(India)
- Product number: SML0268
- Product name : AZD1152-HQPA
- Purity: ≥98% (HPLC)
- Packaging: 50MG
- Price: ₹47208.3
- Updated: 2022/06/14
- Buy: Buy
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- Chemical Properties,Usage,Production
- Description AZD1152-HQPA (722544-51-6) is a potent and highly selective inhibitor of Aurora B.1?Aurora B Ki?= 0.36 nM; Aurora A Ki?= 1,369 nM.2?It inhibits the growth of tumors in multiple cancer models.3-6?Excessive ROS generation7?and upregulated tumor suppressor miRNAs8?have been proposed as a novel mechanisms of cytotoxicity of AZD1152-HQPA.
-
Uses
AZD1152-HQPA has been used:
- for the dose dependent inhibition of aurora kinase B (AURKB)
- as a component to identify that, replication timing regulatory factor 1 (RIF1) and protein phosphatase 1 (PP1) are critical for the regulation of abscission timing in human cells
- as a component to study the relevance of AURKB as a cancer therapeutic target
- Uses AZD1152-HQPA is a a highly selective inhibitor of aurora-B kinase. AZD1152-HQPA has been shown to inhibit osteosarcoma cell line U2-OS cells proliferation. AZD1152-HQPA was also shown to be an effective apoptosis-inducing agent in acute myeloid leukemia cell lines and primary acute myeloid leukemia cultures.
- Definition ChEBI: AZD-1152 is a member of the of quinazolines that is 4-aminoquinazolin-7-ol in which the amino group at position 4 has been substituted by a 5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl group, while the hydroxy group at position 7 has been converted into the corresponding 3-[ethyl(2-hydroxyethyl)aminopropyl ether. It has a role as an antineoplastic agent and an Aurora kinase inhibitor. It is a member of quinazolines, a secondary carboxamide, a tertiary amino compound, a secondary amino compound, a member of pyrazoles, a primary alcohol, a member of monofluorobenzenes and an anilide.
- Biochem/physiol Actions AZD1152-HQPA is the active metabolite of AZD-1152, a potent selective Aurora Kinase B inhibitor. AZD1152 is 50-fold selective for Aurora kinase B over Aurora kinase C and over 1000-fold selective for Aurora kinase B over Aurora Kinase A. (IC50s: aurora-A, 1,369 nmol/L; aurora-B, 0.36 nmol/L; aurora-C, 17.0 nmol/L). It is converted in plasma to the active form AZD1152-HQPA, which has been shown to have antineoplastic activity in a variety of animal models and human cancer cell lines.
- target Aurora B
- References 1) Mortlock?et al. (2007)?Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase; J. Med. Chem.?50?2213 2) Wilkinson?et al.?(2007)?AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis; Clin. Cancer Res.?13?3682 3) Oke?et al.?(2009)?AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo; Cancer Res.?69?4150 4) Aihara?et al.?(2010)?The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma; J. Hepatol.?52?63 5) Mori?et al.?(2011)?Effects of AZD1152, a selective Aurora B kinase inhibitor of Burkitt’s and Hodgkin’s lymphomas; Biochem. Pharmacol.?82?1252 6) Helfrich?et al.?(2016)?Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo; Mol. Cancer Ther.?15?2314 7) Zekri?et al.?(2017)?Reactive oxygen species generation and increase in mitochondrial copy number: new insight into the potential mechanism of cytotoxicity induced by aurora kinase inhibitor, AZD1152-HQPA; Anticancer Drugs?28?841 8) Zekri?et al.?(2018)?The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA); J. Mol. Neurosci.?65?444
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- Preparation Products And Raw materials
Raw materials
Preparation Products
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- Suppliers
Global(166)Suppliers
-
Supplier:
- Tel:+86-(0)57185586718<br/>+86-13336195806
- Email:sales@capot.com
- Country:China
- ProdList:29730
- Advantage:60
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:sales@coreychem.com
- Country:China
- ProdList:29858
- Advantage:58
-
Supplier:
- Tel:86-13657291602
- Email:linda@hubeijusheng.com
- Country:CHINA
- ProdList:22963
- Advantage:58
-
Supplier:
- Tel:027-67849912
- Email:sales@chemwish.com
- Country:CHINA
- ProdList:10821
- Advantage:58
-
Supplier:
- Tel: +8618523575427
- Email:sales@conier.com
- Country:China
- ProdList:49732
- Advantage:58
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32159
- Advantage:58
-
Supplier:
- Tel: +8615255079626
- Email:eric@witopchemical.com
- Country:China
- ProdList:23541
- Advantage:58
-
Supplier:
- Tel:+86-29-89586680<br/>+86-15129568250
- Email:1026@dideu.com
- Country:China
- ProdList:22854
- Advantage:58
-
Supplier:
- Tel:+86-0571-85134551
- Email:sales@afinechem.com
- Country:China
- ProdList:15395
- Advantage:58
-
Supplier:
- Tel:+1-2135480471<br/>+1-2135480471
- Email:sales@sarms4muscle.com
- Country:China
- ProdList:10473
- Advantage:58
1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- Spectrum
722544-51-6, 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-Related Search:
- METHOPRENE ACID N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea methanesulfonate (1:1) NORFLUOXETINE HYDROCHLORIDE Ethyl acetate Ethylhexylglycerin 2-HYDROXYETHYLUREA Decamethylcyclopentasiloxane 4'-Hydroxyacetophenone Hydroxyethyl Cellulose ZM 447439 MK-2206 2HCl Alisertib (MLN8237) Tozasertib BI 2536 MLN8054 Barasertib (AZD1152-HQPA)
- Inhibitor
- API intermediates
- Protein Kinase Inhibitors and Activators
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Heterocycles
- Aromatics
- Inhibitors
- 信号转导通路激酶抑制剂
- 合成有机化合物配体
- 抑制剂
- 细胞生物学试剂
- 小分子抑制剂,天然产物
- 小分子抑制剂
- 细胞周期
- 医药中间体
- C26H30FN7O3
- AZD-1152;AZD-1152-HQPA;AZD-1152-HYDROXYQPA;AZD-2811
- 化合物BARASERTIB,10 MM DMSO 溶液
- AZD1152-HQPA,AURORA B KINASE抑制剂
- BARASERTIB (AZD1152-HQPA),AURORA B激酶抑制剂
- 2-(5-((7-(3-(乙基(2-羟乙基)氨基)丙氧基)喹唑啉-4-基)氨基)-1H-吡唑-3-基)-N-(3-氟苯基)乙酰胺
- 巴拉塞替 (AZD1152-HQPA)
- 化合物BARASERTIB
- AURORA B抑制剂(AZD1152-HQPA)
- 巴拉塞替-HQPA
- 5-[[7-[3-[乙基(2-羟基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺
- 722544-51-6
- AZD-1152-hydroxyQPA
- Barasertib-HQPA, 10 mM in DMSO
- AZD1152-HQPA, Aurora B kinase inhibitor
- Defosbarasertib
- AZD1152-HQPA Aurora B kinase inhibitor ab142049
- AZD-1152HQPA
- AZD1152-HQPA
- AZD-2811
- Barasertib (AZD1152-HQPA)
- Barasertib
- Barasertib (AZD1152-HQPA|AZD2811)
- Barasertib ( INH-34
- 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)- USP/EP/BP
- AZD1152-HQPA|AZD2811
- 1H-Pyrazole-3-acetamide
- AZD1152-HQPA;BARASERTIB;AZD1152;AZD 1152;INH 34
- Barasertib-HQPA
- AZD1152; AZD-1152
- CS-41
- AZD-2811; AZD 2811; AZD2811; AZD-1152HQPA; AZD 1152HQPA; AZD1152HQPA; AZD1152 HQPA; AZD1152-HQPA; AZD1152HQPA.
- 2-(5-((7-(3-(Ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-3-yl)-N-(3-f
- BARASERTIB (AZD1152-HQPA);AZD1152; AZD 1152
- Barasertib, >=98%
- 3-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-5-acetamide
- AZD1152-HQPA 5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide
- 5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide AZD1152-HQPA
- 2-(5-(7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-ylamino)-1H-pyrazol-3-yl)-N-(3-fluorophenyl)acetamide
- AZD1152 HPQA
- 2-[5-(7-{3-[ETHYL-(2-HYDROXY-ETHYL)-AMINO]-PROPOXY}-QUINAZOLIN-4-YLAMINO)-2H-PYRAZOL-3-YL]-N-(3-FLUORO-PHENYL)-ACETAMIDE
- 1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-